Melanoma Cancer Diagnostics Market
Melanoma Cancer Diagnostics Market Analysis by Fluorescent In-Situ Hybridization (FISH) Tests, Comparative Genomic Hybridization (CGH) Tests, and Immunohistochemical (IHC) Tests from 2023 to 2033
Analysis of Melanoma Cancer Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Melanoma Cancer Diagnostics Market Outlook (2023 to 2033)
The global melanoma cancer diagnostics market accounts for a valuation of US$ 4.6 billion in 2023 and is extrapolated to secure a revenue of US$ 8.9 billion by the end of 2033. Over the next ten years, global demand for melanoma cancer diagnostics is forecasted to rise at 6.8% CAGR.
Melanoma is a serious type of skin cancer that develops in melanocytes and is responsible for a majority of deaths related to skin cancer across the world.
- Despite melanoma only accounting for 1% of total skin cancer cases, demand for its diagnosis and treatment is increasing rapidly owing to the high mortality rates associated with it.
The prevalence of all types of cancers has increased noticeably in the past few years and this is a key factor that is anticipated to boost demand for skin cancer diagnostics, breast cancer diagnostics, etc. over the coming years. Surging demand for early diagnosis of melanoma around the world is also slated to uplift sales of melanoma cancer diagnostic products through 2033.
The rising popularity of minimally-invasive diagnostic procedures, increasing prevalence of cancer, growing preference for preventive healthcare, and increasing healthcare expenditure are other factors that could augment sales of melanoma cancer diagnostic devices over the next ten years. The launch of several new initiatives to promote awareness about skin cancer conditions is also expected to supplement market growth in the future.
- In January 2023, The Hospital Research Foundation, Skin Check Champions, and the University of South Australia collaborated to launch a pop-up clinic that utilizes artificial intelligence (AI) technology to diagnose skin cancer.
Surging investments in research and development of novel diagnostic and treatment procedures for melanoma by governments and non-profit organizations are also expected to bolster sales of melanoma diagnosis and treatment products.
- In October 2022, Warwickshire (UHCW) NHS Trust and University Hospitals Coventry, announced the launch of a new trial that has the potential to revolutionize the future of skin cancer treatment and diagnosis. The study was expected to use an innovative device dubbed ‘skinometer’, which aids in determining how far cancers have reached under the skin.
On the flip side, the dearth of skilled medical professionals to operate and monitor advanced melanoma cancer diagnostic equipment is expected to hamper market development across the forecast period. Furthermore, the high costs of diagnostic equipment and diagnostic procedures are also anticipated to constrain melanoma cancer diagnostic demand going forward.
| Report Attributes | Details |
|---|---|
| Melanoma Cancer Diagnostics Market Size (2023) | US$ 4.6 Billion |
| Projected Market Value (2033F) | US$ 8.9 Billion |
| Global Market Growth Rate (2023 to 2033) | 6.8% CAGR |
| Market Share of Pathology Laboratories (2033F) | > 50% |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; Quest Diagnostics Incorporated; bioMerieux SA; QIAGEN; Illumina Inc.; Inivata Ltd.; F. Hoffman-La Roche Ltd.; Agilent Technologies Inc.; Abbott; Myriad genetics; Nanostring; Damae Medical; DermLite; Neracare GmbH; VERISKIN INC. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Start-ups are Altering the Future of Skin Cancer Diagnostics?
“Start-up Ecosystem led by AMLo Biosciences, Geneseq Biosciences, and ANAPIX Medical”
Increasing awareness regarding melanoma around the world has resulted in high demand for early diagnosis of the condition as it increases the chances of successful treatment and survival for skin cancer patients. Incoming providers of melanoma cancer diagnostics are focusing on developing novel diagnostic products and solutions that allow easy and fast diagnosis of melanoma.
Growing use of AI in diagnostics is a major trend that almost all upcoming melanoma cancer diagnostic companies are expected to focus on and capitalize on over the coming years.
- ANAPIX medical, a French medical technology start-up founded in 2016, has developed a decision support algorithm called DIAMELA that allows clinicians to diagnose melanoma by leveraging artificial intelligence technology to analyze dermoscopic images of melanocytic lesions. The company also provides an algorithm that utilizes pathology databases to identify melanoma-related anomalies, which is named SKINAN.
- An Australian start-up founded in 2017 called Geneseq Biosciences, is offering liquid biopsy testing solutions for medical professionals to identify skin cancer in their patients. The company offers ‘Melseq’, a test that is capable of measuring 38 microRNAs and could also be able to trace the genetic fingerprint of melanoma.
- AMLo Biosciences, a new company focused on developing revolutionary diagnostics products using cancer biomarkers, is investing in the creation of a prognostic test named ‘AMBLor’ for stage 1 and stage 2 melanoma detection. The test is based on two protein markers namely loricrin and AMBRA1.
New melanoma cancer diagnosis providers are also focusing on bagging new capital to fund their research and expansion efforts and compete with established players in the global landscape.
- In September 2020, Skin Analytics, a start-up based in the United Kingdom, announced that it had raised US$ 4.89 billion in a Series A funding round that was led by Hoxton Ventures. The company had developed an artificial intelligence-based skin cancer screening service and had plans to use the raised capital to expand its business in the United States.
An exhaustive and detailed assessment of how new developments by start-ups are affecting local supply, product standards, and other industry-altering trends has been listed in this latest melanoma cancer diagnostics industry survey by Fact.MR, a market research and competitive intelligence provider.
Country-wise Insights
Should Melanoma Cancer Diagnostic Providers Invest in the United States?
“Surging Investments in Cancer Research in the Country”
Cases of melanoma and other types of cancers have been increasing in the United States over the past few years and this is projected to uplift the demand for melanoma cancer diagnostics across the forecast period as well.
- The American Cancer Society estimated that around 97,610 new cases of melanoma will be recorded in the United States in 2023 and the mortality for the same would be 7,990 people.
Increasing awareness regarding melanoma diagnosis, the presence of key medical device companies, the high availability of skilled medical professionals, and rising investments in medical research and development by companies and the government are other aspects that could augment market growth in the country through 2033.
Which Countries are Crucial Markets in the APAC Region?
“Australia, China, New Zealand, and Korea to Be Prime Markets”
The prevalence of melanoma in the East and Southeast Asian regions is comparatively lower than it is in North America. However, Asian melanoma patients are generally diagnosed with advanced disease and this is what results in a high mortality rate among Asian skin cancer patients. Australia, New Zealand, China, and South Korea are some countries where the incidence of melanoma is higher than in other APAC countries.
Increasing investments in the development of healthcare infrastructure, a rising number of clinical trials for melanoma diagnosis and treatment, and high mortality rates are other factors that could influence shipments of melanoma cancer diagnostic devices in the region going forward.
Where Will Melanoma Cancer Diagnostic Demand Soar in Europe?
“Germany and United Kingdom – Leading Markets in Europe”
Incidence of melanoma in Germany and the United Kingdom has been increasing in recent years and this is a key factor that is predicted to bolster demand for melanoma cancer diagnostics throughout the forecast period and beyond.
- As per Cancer Research UK, on average 16,700 new cases of melanoma cancer are recorded in the United Kingdom each year, and is the 5th most common type of cancer in the country.
Increased life expectancy and rising UV (ultraviolet exposure) are anticipated to be major factors driving up the number of melanoma cancer patients in the majority of European countries. Increasing healthcare expenditure and rising investments in cancer research are also expected to crucially augment melanoma cancer diagnostics market growth trajectory in Germany and the United Kingdom over the next ten years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Where Will Demand for Melanoma Cancer Diagnostics Shine Bright?
“Pathology Labs to Lead Skin Cancer Diagnostic Product Sales”
Based on end user, the melanoma cancer diagnostics market is segmented into hospitals, pathology laboratories, and cancer research centers.
Pathology laboratories provide critical information on melanoma progression in patients and also aid in the apt diagnosis of the condition. The deployment of laboratory information management systems in these pathology labs is also expected to benefit the screening and diagnosis procedure for various skin cancer conditions.
- By the end of the forecast period, pathology laboratories are estimated to account for more than 1/2 of the global melanoma cancer diagnostics market share.
Competitive Landscape
Top providers of melanoma cancer diagnostics are focusing on the development and launch of novel and innovative products that improve the chances of treatment for people suffering from skin cancer.
- In March 2023, Genetic Technologies Limited, a biotechnology company headquartered in Australia, announced the launch of three new disease assessments in its geneType Multi Risk-Test that already was used to test 6 other diseases. Melanoma, atrial fibrillation, and pancreatic cancer are the three new diseases that were added and could be tested by the geneType Multi Risk-Test with just a single saliva sample of the patient.
- In May 2022, Labcorp, a leading life sciences organization, announced the launch of a new immunohistochemistry (IHC) test that measures Lymphocyte-activation gene 3 (LAG-3) expression levels in tumor tissue. The test was available for the treatment of patients as well as clinical trials.
More insights about new developments by leading melanoma cancer diagnostic companies and how they alter future pricing trends have been discussed in detail in this latest Fact.MR research analysis.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments of Melanoma Cancer Diagnostics Industry Research
-
By Test :
- Fluorescent In-Situ Hybridization (FISH) Tests
- Comparative Genomic Hybridization (CGH) Tests
- Immunohistochemical (IHC) Tests
- Others
-
By End User :
- Hospitals
- Pathology Laboratories
- Cancer Research Centers
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Introduction
- 3. Market Dynamics
- 4. Key Inclusion
- 5. Global Market Analysis and Forecast
- 5.1 Market Value Share by Region
- 5.2 Market Size Analysis By Test Type
- 5.2.1 Fluorescent In Situ Hybridization (FISH) Tests
- 5.2.2 Comparative Genomic Hybridization (CGH) Tests
- 5.2.3 Immunohistochemical (IHC) Tests
- 5.3 Market Size Analysis By End User
- 5.3.1 Hospitals
- 5.3.2 Pathology Laboratories
- 5.3.3 Cancer Research Centres
- 6. North America Market Analysis
- 7. Latin America Market Analysis
- 8. Europe Market Analysis
- 9. CIS & Russia Market Analysis
- 10. Asia Pacific ex. Japan Market Analysis
- 11. Japan Market Analysis
- 12. MEA Market Analysis
- 13. Assumptions and Acronyms Used
- 14. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: US Average Test Price (US$), By Test Type
Table 02: Canada Average Test Price (US$), By Test Type
Table 03: Germany Average Test Price (US$), By Test Type
Table 04: France Average Test Price (US$), By Test Type
Table 05: U.K. Average Test Price (US$), By Test Type
Table 06: Spain Average Test Price (US$), By Test Type
Table 07: Italy Average Test Price (US$), By Test Type
Table 08: Australia Average Test Price (US$), By Test Type
Table 09: Market: Regulation and Reimbursement Scenario
Table 10: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
Table 11: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
Table 12: Global Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 13: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 14: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
Table 15: North America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 16: Latin America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 17: Latin America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
Table 18: Latin America Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 19: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 20: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
Table 21: Europe Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 22: CIS & Russia Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 23: CIS & Russia Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
Table 24: CIS & Russia Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 25: APEJ Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 26: APEJ Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
Table 27: APEJ Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 28: Japan Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
Table 29: Japan Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
Table 30: Middle East & Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
Table 31: Middle East & Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
Table 32: Middle East & Africa Market Size (US$ Mn) Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Market Value Share By Region (2018)
Figure 02: Global Market Share, By Region(2023)
Figure 03: Global Market Share, By Test Type (2023)
Figure 04: Global Market Share, By End User (2023)
Figure 05: Global Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 06: Global Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 07: Global Market Attractiveness Analysis, By Region
Figure 08: Global Market Value Share Analysis, By Region, 2023 & 2028
Figure 09: Global Market Attractiveness Analysis, By Test Type
Figure 10: Global Market Value Share Analysis, By Test Type, 2023 & 2028
Figure 11: Global Market Attractiveness Analysis, By End User
Figure 12: Global Market Value Share Analysis, By End User, 2023 & 2028
Figure 13: North America Market, Snapshot
Figure 14: North America Market Value Share, by Country (2023)
Figure 15: North America Market Value Share, by Test Type (2023)
Figure 16: North America Market Value Share, by End User (2023)
Figure 17: North America Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 18: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 19: US Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 20: US Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 21: Canada Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 22: Canada Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 23: North America Market Size (US$ Mn) Analysis, 2018 to 2022, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 24: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 25: North America Market Size (US$ Mn) Analysis, 2018 to 2022, By Comparative Genomic Hybridization (CGH) Tests
Figure 26: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Comparative Genomic Hybridization (CGH) Tests
Figure 27: North America Market Size (US$ Mn) Analysis, 2018 to 2022, By Immunohistochemical (IHC) Tests
Figure 28: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Immunohistochemical (IHC) Tests
Figure 29: North America Market Attractiveness Analysis, By Country
Figure 30: North America Market Attractiveness Analysis, By Test Type
Figure 31: North America Market Attractiveness Analysis, By End User
Figure 32: Latin America Market, Snapshot
Figure 33: Latin America Market Value Share, by Country (2023)
Figure 34: Latin America Market Value Share, by Test Type (2023)
Figure 35: Latin America Market Value Share, by End User (2023)
Figure 36: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 37: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 38: Mexico Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 39: Mexico Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 40: Brazil Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 41: Brazil Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 42: Argentina Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 43: Argentina Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 44: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 45: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 46: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022, By Comparative Genomic Hybridization (CGH) Tests
Figure 47: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Comparative Genomic Hybridization (CGH) Tests
Figure 48: Latin America Market Size (US$ Mn) Analysis, 2018 to 2022, By Immunohistochemical (IHC) Tests
Figure 49: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Immunohistochemical (IHC) Tests
Figure 50: Latin America Market Attractiveness Analysis, By Country
Figure 51: Latin America Market Attractiveness Analysis, By Test Type
Figure 52: Latin America Market Attractiveness Analysis, By End User
Figure 53: Europe Market, Snapshot
Figure 54: Europe Market Value Share, by Country (2023)
Figure 55: Europe Market Value Share, by Test Type (2023)
Figure 56: Europe Market Value Share, by End User (2023)
Figure 57: Europe Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 58: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 59: Germany Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 60: Germany Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 61: France Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 62: France Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 63: UK Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 64: UK Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 65: Spain Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 66: Spain Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 67: Italy Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 68: Italy Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 69: Belgium Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 70: Belgium Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 71: Netherlands Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 72: Netherlands Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 73: Europe Market Size (US$ Mn) Analysis, 2018 to 2022, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 74: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 75: Europe Market Size (US$ Mn) Analysis, 2018 to 2022, By Comparative Genomic Hybridization (CGH) Tests
Figure 76: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Comparative Genomic Hybridization (CGH) Tests
Figure 77: Europe Market Size (US$ Mn) Analysis, 2018 to 2022, By Immunohistochemical (IHC) Tests
Figure 78: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Immunohistochemical (IHC) Tests
Figure 79: Europe Market Attractiveness Analysis, By Country
Figure 80: Europe Market Attractiveness Analysis, By Test Type
Figure 81: Europe Market Attractiveness Analysis, By End User
Figure 82: CIS & Russia Market, Snapshot
Figure 83: CIS & Russia Market Value Share, by Country (2023)
Figure 84: CIS & Russia Market Value Share, by Test Type (2023)
Figure 85: CIS & Russia Market Value Share, by End User (2023)
Figure 86: CIS & Russia Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 87: CIS & Russia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 88: CIS Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 89: CIS Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 90: Russia Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 91: Russia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 92: CIS & Russia Market Size (US$ Mn) Analysis, 2018 to 2022, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 93: CIS & Russia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 94: CIS & Russia Market Size (US$ Mn) Analysis, 2018 to 2022, By Comparative Genomic Hybridization (CGH) Tests
Figure 95: CIS & Russia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Comparative Genomic Hybridization (CGH) Tests
Figure 96: CIS & Russia Market Size (US$ Mn) Analysis, 2018 to 2022, By Immunohistochemical (IHC) Tests
Figure 97: CIS & Russia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Immunohistochemical (IHC) Tests
Figure 98: CIS & Russia Market Attractiveness Analysis, By Country
Figure 99: CIS & Russia Market Attractiveness Analysis, By Test Type
Figure 100: CIS & Russia Market Attractiveness Analysis, By End User
Figure 101: APEJ Market, Snapshot
Figure 102: APEJ Market Value Share, by Country (2023)
Figure 103: APEJ Market Value Share, by Test Type (2023)
Figure 104: APEJ Market Value Share, by End User (2023)
Figure 105: APEJ Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 106: APEJ Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 107: China Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 108: China Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 109: India Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 110: India Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 111: Australia Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 112: Australia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 113: New Zealand Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 114: New Zealand Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 115: Thailand Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 116: Thailand Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 117: APEJ Market Size (US$ Mn) Analysis, 2018 to 2022, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 118: APEJ Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 119: APEJ Market Size (US$ Mn) Analysis, 2018 to 2022, By Comparative Genomic Hybridization (CGH) Tests
Figure 120: APEJ Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Comparative Genomic Hybridization (CGH) Tests
Figure 121: APEJ Market Size (US$ Mn) Analysis, 2018 to 2022, By Immunohistochemical (IHC) Tests
Figure 122: APEJ Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Immunohistochemical (IHC) Tests
Figure 123: APEJ Market Attractiveness Analysis, By Country
Figure 124: APEJ Market Attractiveness Analysis, By Test Type
Figure 125: APEJ Market Attractiveness Analysis, By End User
Figure 126: Japan Market, Snapshot
Figure 127: Japan Market Value Share, by End User (2023)
Figure 128: Japan Market Value Share, by Test Type (2023)
Figure 129: Japan Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 130: Japan Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 131: Japan Market Size (US$ Mn) Analysis, 2018 to 2022, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 132: Japan Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 133: Japan Market Size (US$ Mn) Analysis, 2018 to 2022, By Comparative Genomic Hybridization (CGH) Tests
Figure 134: Japan Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Comparative Genomic Hybridization (CGH) Tests
Figure 135: Japan Market Size (US$ Mn) Analysis, 2018 to 2022, By Immunohistochemical (IHC) Tests
Figure 136: Japan Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Immunohistochemical (IHC) Tests
Figure 137: Japan Market Attractiveness Analysis, By End User
Figure 138: Japan Market Attractiveness Analysis, By Test Type
Figure 139: Middle East & Africa Market, Snapshot
Figure 140: Middle East & Africa Market Value Share, by Country (2023)
Figure 141: Middle East & Africa Market Value Share, by Test Type (2023)
Figure 142: Middle East & Africa Market Value Share, by End User (2023)
Figure 143: Middle East & Africa Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 144: Middle East & Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 145: South Africa Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 146: South Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 147: Turkey Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 148: Turkey Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 149: GCC Countries Market Size (US$ Mn) Analysis, 2018 to 2022
Figure 150: GCC Countries Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033
Figure 151: Middle East & Africa Market Size (US$ Mn) Analysis, 2018 to 2022, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 152: Middle East & Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Fluorescent In Situ Hybridization (FISH) Tests
Figure 153: Middle East & Africa Market Size (US$ Mn) Analysis, 2018 to 2022, By Comparative Genomic Hybridization (CGH) Tests
Figure 154: Middle East & Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Comparative Genomic Hybridization (CGH) Tests
Figure 155: Middle East & Africa Market Size (US$ Mn) Analysis, 2018 to 2022, By Immunohistochemical (IHC) Tests
Figure 156: Middle East & Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2023 to 2033, By Immunohistochemical (IHC) Tests
Figure 157: Middle East & Africa Market Attractiveness Analysis, By Country
Figure 158: Middle East & Africa Market Attractiveness Analysis, By Test Type
Figure 159: Middle East & Africa Market Attractiveness Analysis, By End User
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current size of the melanoma cancer diagnostics market?
The global melanoma cancer diagnostics market stands at US$ 4.6 billion in 2023.
How big will the market for melanoma cancer diagnostics be by 2033?
Melanoma cancer diagnostic product sales are forecasted to reach US$ 8.9 billion by the end of 2033.
At what pace will the demand for melanoma cancer diagnostics rise?
From 2023 to 2033, melanoma cancer diagnostic demand is extrapolated to rise at 6.8% CAGR.
How many people will be diagnosed with melanoma in the United States this year?
More than 97,000 people are estimated to be diagnosed with melanoma in the United States in 2023.
Who are the leading companies in this industry?
Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, bioMerieux SA, QIAGEN, and Illumina Inc. are prime companies in the global market.
Melanoma Cancer Diagnostics Market